Oxford Nanopore valued at nearly $5 billion after setting IPO price

(Reuters) – Oxford Nanopore has priced its London initial public offering at 425 pence per share, a bookrunner said on Tuesday, giving it an expected market valuation of around 3.6 billion pounds ($4.92 billion) including its use of a greenshoe option.

The IPO of the provider of rapid COVID-19 tests to Britain’s national health services would be significant for the London Stock Exchange as most British pharma and life science companies tend to list on New York’s Nasdaq.

($1 = 0.7311 pounds)

Source: Read Full Article